PHARMEDAILY

Sellbion CEO Kwon Kim: “Maximizing the Power of 177Lu-DGUL Immuno-Oncology Combo”

• 유진희
• 2025.07.21
• 오전 09:30

Cellbion’s radiotherapy shows 35% ORR, looks to expand Merck ties

• 유진희
• 2025.09.05
• 오전 08:30